Post-liver transplantation diabetes mellitus (PLTDM) develops in up to 30% of liver
transplant recipients and is associated with increased risk of mortality and multiple morbid …

Uncontrolled type 2 diabetes mellitus (T2DM) and post‐transplant diabetes mellitus (PTDM)
increase morbidity and mortality after kidney transplantation. Conventional strategies for …

Post-transplant diabetes mellitus is a frequent complication of solid organ transplantation
that generally requires treatment with lifestyle interventions and antidiabetic medication. A …

Background Kidney transplantation is the preferred management for patients with end‐stage
kidney disease (ESKD). However, it is often complicated by worsening or new‐onset …

Patients who undergo solid organ transplantation may have preexisting diabetes mellitus
(DM), which puts them at increased risk from any surgery. 1 It is important to evaluate the …

Objective This systematic review describes the efficacy, safety, and drug interactions of
dipeptidyl peptidase-4 (DPP-4) inhibitors, glucagon-like peptide-1 receptor agonists (GLP-1 …

Worldwide, the prevalence obesity, diabetes, and chronic kidney disease is increasing
apace. The relationship between obesity and chronic kidney disease is multidimensional …

Post-transplantation diabetes mellitus (PTDM) remains a leading complication after solid
organ transplantation. Previous international PTDM consensus meetings in 2003 and 2013 …

Post-transplant diabetes mellitus (PTDM) is a common problem after kidney transplantation
(KT), occurring in 50% of high-risk recipients. The clinical importance of PTDM lies in its …

Aims We aimed to conduct a systematic review and meta-analysis regarding the use of
incretin-based therapies including dipeptidyl peptidase-4 (DPP-4) inhibitors and glucagon …